Austin Donnelly Evans

Austin Donnelly Evans

Auto-generated profile, based on publicly available information

Austin Donnelly Evans

Bioengineering and Nanomedicine Group, Faculty of Medicine and Health Technologies, Tampere University, 33720, Tampere, Finland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2025 in Biomaterials
Verified
Journal Article
Open access
KRKaveh Roshanbinfar
Kaveh Roshanbinfar
AEAustin Donnelly Evans
Austin Donnelly Evans
SSSumanta Samanta
Sumanta Samanta
MKMaria Kolesnik-Gray
Maria Kolesnik-Gray
MFMaren Fiedler
Maren Fiedler
OVOommen Varghese
Oommen Varghese
Biofabrication represents a promising technique for creating tissues for regeneration or as models for drug testing. Collagen-based hydrogels are widely used as suitable matrix owing to their biocompatibility and tunable mechanical properties. However, one major challenge is that the encapsulated cells interact with the collagen matrix causing construct shrinkage. Here, we present a hydrogel with high shape fidelity, mimicking the major components of the extracellular matrix. We engineered a composite hydrogel comprising gallic acid (GA)-functionalized hyaluronic acid (HA), collagen I, and HA-coated multiwall carbon nanotubes (MWCNT). This hydrogel supports cell encapsulation, exhibits shear-thinning properties enhancing injectability and printability, and importantly significantly mitigates shrinkage when loaded with human fibroblasts compared to collagen I hydrogels (∼20 % vs. > 90 %). 3D-bioprinted rings utilizing human fibroblast-loaded inks maintain their shape over 7 days in culture. Furthermore, inclusion of HAGA into collagen I hydrogels increases mechanical stiffness, radical scavenging capability, and tissue adhesiveness. Notably, the here developed hydrogel is also suitable for human induced pluripotent stem cell-derived cardiomyocytes and allows printing of functional heart ventricles responsive to pharmacological treatment. Cardiomyocytes behave similar in the newly developed hydrogels compared to collagen I, based on survival, sarcomere appearance, and calcium handling. Collectively, we developed a novel material to overcome the challenge of post-fabrication matrix shrinkage conferring high shape fidelity.

22 May 2024 in Biomaterials
Verified
Journal Article
Open access
AEAustin D. Evans
Austin D. Evans
NPNegin Pournoori
Negin Pournoori
ESEmmi Saksala
Emmi Saksala
OVOommen Varghese
Oommen Varghese
Dysfunction of the central nervous system (CNS) following traumatic brain injuries (TBI), spinal cord injuries (SCI), or strokes remains challenging to address using existing medications and cell-based therapies. Although therapeutic cell administration, such as stem cells and neuronal progenitor cells (NPCs), have shown promise in regenerative properties, they have failed to provide substantial benefits. However, the development of living cortical tissue engineered grafts, created by encapsulating these cells within an extracellular matrix (ECM) mimetic hydrogel scaffold, presents a promising functional replacement for damaged cortex in cases of stroke, SCI, and TBI. These grafts facilitate neural network repair and regeneration following CNS injuries. Given that natural glycosaminoglycans (GAGs) are a major constituent of the CNS, GAG-based hydrogels hold potential for the next generation of CNS healing therapies and in vitro modeling of CNS diseases. Brain-specific GAGs not only offer structural and biochemical signaling support to encapsulated neural cells but also modulate the inflammatory response in lesioned brain tissue, facilitating host integration and regeneration. This review briefly discusses different roles of GAGs and their related proteoglycan counterparts in healthy and diseases brain and explores current trends and advancements in GAG-based biomaterials for treating CNS injuries and modeling diseases. Additionally, it examines injectable, 3D bioprintable, and conductive GAG-based scaffolds, highlighting their clinical potential for in vitro modeling of patient-specific neural dysfunction and their ability to enhance CNS regeneration and repair following CNS injury in vivo.

3 November 2025 in Advanced Science
Verified
Journal Article
Open access
VJVadim Le Joncour
Vadim Le Joncour
AEAustin D. Evans
Austin D. Evans
CBCamilla Karoliina Bergström
Camilla Karoliina Bergström
VRVignesh Kumar Rangasami
Vignesh Kumar Rangasami
SSSumanta Samanta
Sumanta Samanta
OVOommen Varghese
Oommen Varghese
Glioblastomas (GB) are the most common and deadly primary malignant brain tumors due to their infiltrative growth and resistance to conventional therapies. GB cell plasticity and differentiation into drug‐resistant mesenchymal‐like (MES) states protect tumors from conventional treatments. This study introduces a novel precision medicine approach employing heparin‐based nanoparticles (HP‐NPs) engineered to cross the blood‐brain barrier and target MES‐like glioma stem cells (GSCs). Encapsulating doxorubicin (DOX) in HP‐NPs reduces drug‐mediated complement and coagulation cascades, enhancing hemocompatibility in human whole blood. In vitro, HP‐NPs demonstrate efficient uptake by patient‐derived GSCs. Preclinical evaluations in patient avatars indicate plain HP‐NPs outperform DOX‐loaded HP‐NPs in reducing GB progression. Transcriptomic studies show HP‐NPs downregulate heparin‐binding epidermal growth factor (HBEGF), shifting MES GSCs into less plastic astroglial‐like cells, impairing tumorigenesis. HP‐NPs are well‐tolerated and safe at therapeutic doses in healthy rats, offering a promising new paradigm in anticancer therapy to overcome GB recurrence and improve therapeutic outcomes.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
SSSumanta Samanta
Sumanta Samanta
VRVignesh Kumar Rangasami
Vignesh Kumar Rangasami
HSHeela Sarlus
Heela Sarlus
JSJay R.K. Samal
Jay R.K. Samal
AEAustin D. Evans
Austin D. Evans
OVOommen Varghese
Oommen Varghese
Novel scaffold designs that enable favorable biomaterial-host interactions by modulating the local inflammatory microenvironment through favorable macrophage polarization and suppressing oxidative stress are needed for successful clinical translation of regenerative cell therapies and graft integration. We herein report derivation of a hydrazone-crosslinked gallol functionalized hyaluronic acid (HA-GA)-based hydrogel that displayed excellent viscoelastic properties and immunomodulatory characteristics. Grafting of 6% gallol (GA) to HA-backbone formed an interpenetrative network by promoting an additional crosslink between the gallol groups in addition to hydrazone crosslinking that significantly enhanced the mechanical stability, as evident from ≈14-fold higher storage modulus in HA-GA gels than HA-HA gels after 21 days of incubation in PBS and displayed shear-thinning/self-healing characteristics. Grafting of GA to the HA backbone in the hydrogel also facilitated tissue adhesive properties to porcine tissue and displayed radical scavenging properties and protected the encapsulated fibroblast cells from peroxide challenge, as ≈78% fibroblast cells were viable in HA-GA gels compared to only ≈50% in hydrazone-crosslinked HA-HA gels lacking gallol groups. The THP-1 human macrophage cell line or primary bone-marrow-derived murine macrophages cultured within HA-GA gels displayed selective polarization to a predominantly anti-inflammatory phenotype by upregulating IL4ra, IL-10, TGF-β, and TGF-βR1 when compared with HA-HA gels. Conversely, culturing of pro-inflammatory activated primary murine macrophages in HA-GA gels resulted in a significant reduction of pro-inflammatory marker expression, such as TNF-α, IL-1β, SOCS3 and IL-6, and upregulated expression of anti-inflammatory cytokines such as TGF-β. Finally, when the gels were implanted subcutaneously in healthy mice we observed infiltration of pro-inflammatory myeloid cells in HA-HA gels while immunosuppressive characteristics were observed within the HA-GA gels. Taken together these data suggest that HA-GA gels are an ideal injectable scaffold for viable immunotherapeutic interventions.

21 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AEAustin Donnelly Evans
Austin Donnelly Evans
JKJenni Keränen
Jenni Keränen
SRSasa Rauhalinna
Sasa Rauhalinna
MMMandana Mombeinipour
Mandana Mombeinipour
HHHasibul Hossain
Hasibul Hossain
Vesa HytönenVesa Hytönen
Vesa Hytönen
Engineering extracellular matrix (ECM) mimetic materials that combine molecular precision of synthetic material options with native biological complexity remains a central challenge in biomaterials science. Here, we present a genetically programmable hydrogel platform that enables independent control of mechanical and biological properties including matrix composition, mechanics, viscoelasticity, and biochemical signaling using recombinant human ECM building blocks assembled via isopeptide chemistry. Modular protein ECM crosslinkers containing complete folded ECM domains equipped with terminal SpyTag peptides were integrated within SpyCatcher-functionalized interchangeable natural polysaccharide backbones to generate fully defined matrices with decoupled material parameters. Point mutations on crosslinker SpyTags within the bond interface varied bond affinity from covalent to physical bonding, allowing tuned stress-relaxation behaviors across physiologically relevant regimes without altering matrix composition nor stiffness. Using colorectal cancer models, we show that polymer identity and matrix viscoelasticity independently regulate spheroid growth, invasion capabilities, and dispersion. Importantly, recombinant ECM domains recapitulated native adhesion functions and provide a structurally encoded layer of biological information. This hydrogel platform provides a molecular framework for constructing precision recombinant human ECM mimics with broad applicability across biomaterials science, mechanobiology, disease modeling, tissue engineering, and regenerative medicine.